Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 3, 2017 at 10:55 AM EDT

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of…

Paul Ausick | Sep 29, 2017 at 4:01 PM EDT

Nike, Merck Weigh on DJIA Friday

The Dow Jones Industrial Average closed essentially flat on Friday, with Nike and Merck posting the largest losses and Goldman…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Paul Ausick | Sep 22, 2017 at 4:01 PM EDT

Apple, UnitedHealth Weigh on DJIA Friday

Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.

Paul Ausick | Sep 14, 2017 at 4:01 PM EDT

United Technologies, Pfizer Lead DJIA Higher on Thursday

United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.

Chris Lange | Sep 14, 2017 at 1:35 PM EDT

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 30, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Blackstone, Ciena, Merck, Tempur Sealy, Universal Display and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Douglas A. McIntyre | Aug 15, 2017 at 4:58 AM EDT

6 Most Important Things in Business Today

The Commerce Department reports that more than 15 million jobs could be affected by self-driving cars, many major hedge funds…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Aug 8, 2017 at 4:01 PM EDT

Merck, DuPont Lead Dow Lower on Tuesday

Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes…

Paul Ausick | Jul 27, 2017 at 4:01 PM EDT

Verizon, Boeing Bolster DJIA Thursday

Verizon, Boeing, Merck, and Disney were Thursday's leading DJIA gainers.

1 … 26 27 28 29 30 … 72

Merck : MRK

All Merck Articles

Short Sellers Run for Cover From Major Pharma

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Nike, Merck Weigh on DJIA Friday

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Apple, UnitedHealth Weigh on DJIA Friday

United Technologies, Pfizer Lead DJIA Higher on Thursday

Why Pfizer Is Pushing the Dow to All-Time Highs

Major Pharma Short Interest Surges

Top Analyst Upgrades and Downgrades: Blackstone, Ciena, Merck, Tempur Sealy, Universal Display and More

Short Sellers Run for Cover From Major Pharma

6 Most Important Things in Business Today

Short Sellers Hike Bets in Major Pharma

Merck, DuPont Lead Dow Lower on Tuesday

Verizon, Boeing Bolster DJIA Thursday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Merck : MRK

All Merck Articles

Short Sellers Run for Cover From Major Pharma

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Nike, Merck Weigh on DJIA Friday

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Apple, UnitedHealth Weigh on DJIA Friday

United Technologies, Pfizer Lead DJIA Higher on Thursday

Why Pfizer Is Pushing the Dow to All-Time Highs

Major Pharma Short Interest Surges

Top Analyst Upgrades and Downgrades: Blackstone, Ciena, Merck, Tempur Sealy, Universal Display and More

Short Sellers Run for Cover From Major Pharma

6 Most Important Things in Business Today

Short Sellers Hike Bets in Major Pharma

Merck, DuPont Lead Dow Lower on Tuesday

Verizon, Boeing Bolster DJIA Thursday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts